Literature DB >> 30186494

Quantification of nitric oxide by high-performance liquid chromatography-fluorometric method in subgenomic hepatitis C virus-replicon expressing Huh7 cells upon treatment with acetylsalicylic acid.

Clara Patricia Rios-Ibarra1,2, Victor Torres-De La Cruz3, Andrea Gabriela Ochoa-Ruiz2, Ana María Rivas-Estilla1.   

Abstract

As nitric oxide (NO) expression levels are lower in hepatocytes compared with other cell types, it is difficult to quantify this compound via Griess assay. The aim of the present study was to quantify NO concentration in the cell culture medium from a subgenomic hepatitis C virus (HCV)-replicon expressing Huh-7 cell system using a high-performance liquid chromatography (HPLC)-fluorescence detector in the presence or absence of acetylsalicylic acid (ASA) treatment. HCV-replicon cells were incubated with ASA (4 mM) for 24, 48 and 72 h. Thereafter, the medium was collected to measure nitrites (NO2-) as an indirect indicator of NO levels using diaminonaphtalene as a derivate agent. NO levels were significantly higher (1.7-fold) in Huh-7 replicon cells treated with ASA (72 h post-treatment) than untreated cells (P<0.05); NO inhibitor reduced ~30% the level of NO in Huh-7 replicon cells treated with ASA (48 h post-treatment; P<0.05). The findings suggested that the HPLC-fluorescence method provided an accurate and efficient measurement of NO production in Huh-7-HCV-replicon cells culture medium.

Entities:  

Keywords:  acetylsalicylic acid; hepatitis C virus; high-performance liquid chromatography; nitric oxide

Year:  2018        PMID: 30186494      PMCID: PMC6122491          DOI: 10.3892/etm.2018.6515

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  33 in total

1.  Using the Griess colorimetric nitrite assay for measuring aliphatic β-nitroalcohols.

Authors:  Quan Wen; David C Paik
Journal:  Exp Eye Res       Date:  2012-03-03       Impact factor: 3.467

2.  Use of proteomic analysis tools to identify HCV-proteins down-regulated by acetylsalicylic acid.

Authors:  Adriana Sánchez-García; Clara Patricia Ríos-Ibarra; Ana Rosa Rincón-Sánchez; Rocío Ortiz-López; Aurora Garza-Juárez; Jesús Morlett-Chávez; Herminia Martínez-Rodríguez; Ana María Rivas-Estilla
Journal:  Ann Hepatol       Date:  2013 Sep-Oct       Impact factor: 2.400

Review 3.  Measurement of NO in biological samples.

Authors:  C Csonka; T Páli; P Bencsik; A Görbe; P Ferdinandy; T Csont
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

4.  Characterization of a fluorescent probe for imaging nitric oxide.

Authors:  Yohannes T Ghebremariam; Ngan F Huang; Swetha Kambhampati; Katharina S Volz; Gururaj G Joshi; Eric V Anslyn; John P Cooke
Journal:  J Vasc Res       Date:  2013-12-11       Impact factor: 1.934

5.  Endothelial nitric-oxide synthase activation generates an inducible nitric-oxide synthase-like output of nitric oxide in inflamed endothelium.

Authors:  Jessica L Lowry; Viktor Brovkovych; Yongkang Zhang; Randal A Skidgel
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

6.  Methylated N(ω)-hydroxy-L-arginine analogues as mechanistic probes for the second step of the nitric oxide synthase-catalyzed reaction.

Authors:  Kristin Jansen Labby; Huiying Li; Linda J Roman; Pavel Martásek; Thomas L Poulos; Richard B Silverman
Journal:  Biochemistry       Date:  2013-04-26       Impact factor: 3.162

7.  Improved methods to measure end products of nitric oxide in biological fluids: nitrite, nitrate, and S-nitrosothiols.

Authors:  M Marzinzig; A K Nussler; J Stadler; E Marzinzig; W Barthlen; N C Nussler; H G Beger; S M Morris; U B Brückner
Journal:  Nitric Oxide       Date:  1997-04       Impact factor: 4.427

8.  Aspirin increases nitric oxide formation in chronic stable coronary disease.

Authors:  Scott Hetzel; David DeMets; Ricky Schneider; Steven Borzak; Wendy Schneider; Victor Serebruany; Henning Schröder; Charles H Hennekens
Journal:  J Cardiovasc Pharmacol Ther       Date:  2013-03-21       Impact factor: 2.457

9.  Nitric oxide and interleukin-1β stimulate the proteasome-independent degradation of the retinoic acid hydroxylase CYP2C22 in primary rat hepatocytes.

Authors:  Choon-myung Lee; Bang-sub Lee; Samuel L Arnold; Nina Isoherranen; Edward T Morgan
Journal:  J Pharmacol Exp Ther       Date:  2013-10-21       Impact factor: 4.030

10.  Acetylsalicylic acid inhibits hepatitis C virus RNA and protein expression through cyclooxygenase 2 signaling pathways.

Authors:  Karina Trujillo-Murillo; Ana Rosa Rincón-Sánchez; Herminia Martínez-Rodríguez; Francisco Bosques-Padilla; Javier Ramos-Jiménez; Hugo A Barrera-Saldaña; Marcos Rojkind; Ana María Rivas-Estilla
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

View more
  1 in total

1.  A Comparison of Different Approaches to Quantify Nitric Oxide Release from NO-Releasing Materials in Relevant Biological Media.

Authors:  Rosana V Pinto; Fernando Antunes; João Pires; Ana Silva-Herdade; Moisés L Pinto
Journal:  Molecules       Date:  2020-06-02       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.